Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: 3D Medicines, Aim Immunotech, Algernon, Alphamab Oncology, Aslan, Astellas, Astrazeneca, Atossa, Atyr, Beigene, Clinuvel, Direct Biologics, Eli Lilly, Galera, Kyorin, Leap, Onconova, Opko Health, Rigel, Roche, Tracon.

Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief, including: Abound, Alaxia, Amgen, Axon, Betterlife, Biontech, Bristol Myers Squibb, C3.ai, Cebina, Cend, Dr. Reddy’s, Dyadic International, Eisai, Eli Lilly, Emergex, Eyevance, Fosun, Foundation Medicine, Generex, Genexine, Hepion, Hoth, Humanigen, Immunoprecise, Impilo, Janone, Jiangsu Hengrui Medicine, Junshi, Kiadis, Lonza, Mabion, Melior, Mylan, Nanoviricides, Neurorx, Novartis, Novavax, Octimet, Panolos, Pfizer, Pharmajet, Raziel, Relief, Revive, Samsung Biologics, Santen, Shanghai Fosun, Takeda, Teva, Tianjin Juvestar, Tiziana Life Sciences, Tonix, Transcenta Biomedical (Shanghai), Ufovax, Vaxine, Wigen Biomedicine, Xbiotech, Yufan, Zymeworks.

Biopharmas in Asia-Pacific raising money in public or private financings, including: Humanigen, Xwpharma, Zai Lab.

New hires and promotions in the biopharma industry in Asia-Pacific, including: Brii Biosciences, Sumitomo Dainippon.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Alsa Ventures, Arrow Electronics, Avricore Health, Boeing, Cloud Dx, Detectachem, Elitechgroup, Healthe, MDx, Medigate, Neo Medical, Orthofix, Renalytix AI, Second Sight, Todos, Transmed7, Vivalnk.

The latest global regulatory news, changes and updates affecting medical devices and technologies, including: Life Spine, Medhub, Medtronic, Nanovibronix, Radlogics, Rti Surgical.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Clinical Genomics, Owlstone Medical, Precision Diabetes.

Med-tech firms raising money in public or private financings, including: Pedra Technology, Varex Imaging.

New hires and promotions in the med-tech industry, including: Caption Health, Inivata, Labconnect, Microvention, U.S. Physical Therapy.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: ADC, BMS, Crispr, Emmetrope, Genocea, Knight, Lilly, Medeor, Mustang, Nicox, Ocumension, Redhill, Therapeuticsmd, UCB, Vertex.